ORIENTBIO

오리엔트바이오KRX: 002630· Fiscal year 2025· orientbio.co.kr ↗

Average salary
$24.7K
₩32.9M
▲ 7.9% vs 2024
Employees
123
▲ 16.0% vs 2024
Average tenure
4.4 yrs

Estimated take-home of this pay:$1.8K / monthCalculate →

Workplace

Women's pay (men = 100)72
Women among staff50.4%
Contract staff0%

Recent official filings

Quick read

  • Average pay is 46% below the median of the companies we track.
  • Average pay rose 7.9% from 2024.
  • Headcount grew by 17 (16.0%) from 2024.
  • Ranks #236 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 5.0% year over year.
  • Operating loss of $2.3M in 2025.

Last 3 years

Revenue
$21.6M2023$21.0M2024$22.1M2025
Operating income
$1.1M2023-$484.9K2024-$2.3M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$179.0K
Net profit per employee
-$80.3K
Operating margin
-10.5%
Net margin
-44.9%
ROE
-18.4%
Debt-to-equity
18.0%
Equity ratio
84.7%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.